press releases
TaBriX joins the Venture Road UK initiative in London
On 9th June 2026, TaBriX joined the Venture Road UK initiative in London, connecting with an excitin…
TabriX presents at the Venture Café, Manchester, organised by Nucleate
Professor Lydia Tabernero, founder of TaBriX, joined innovators, founders and investors at Venture C…
Bionow BioInfect 2026, Alderley Park
TaBriX founder Dr Lydia Tabernero recently spoke at the Bionow BioInfect 2026 conference, held at Al…
Dr Lydia Tabernero Represents TaBriX at BIO-Europe Spring 2026 in Lisbon
TaBriX was proud to be represented at BIO-Europe Spring 2026, where founder Dr Lydia Tabernero spoke…
TaBriX has welcomed first private investment
TaBriX has welcomed their first private investment to fund their work.
TaBriX receives award from the ERDF
TaBriX has received an award from the European Regional Development Fund Research and Innovation Hea…
TaBriX awarded by UoM Innovation Factory
TaBriX has recently received a Proof-of-Principle award from the University of Manchester Innovation…
TaBriX awarded by incate
TaBriX has received an award for €10,000 from INCATE, an Incubator for AntibacterialTherapies in Eur…
Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight
Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight
TaBrix receives award from health accelerator
TaBriX has received an award from the Manchester Health Innovation Accelerator Project ERDF for SMEs…
TaBriX and UoM working with TB Alliance to develop novel drugs to treat drug-resistant tuberculosis
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create …
WHO releases 2021 global TB report
The World Health Organisation has released their 2021 Global TB Report. According to the WHO’s…
Scientists develop a new drug treatment for tb
Scientists at The University of Manchester have developed the first non-antibiotic drug to successfu…
new drug to stop tuberculosis epidemic
Researchers at The University of Manchester are developing a new drug against tuberculosis (TB), one…